Pediatrix Medical (MD) FCF Margin (2009 - 2026)

Pediatrix Medical has disclosed FCF Margin across 18 years of filings, most recently posting 28.58% for Q1 2026.

• In Q1 2026, FCF Margin fell 252.0% year-over-year to 28.58%; the TTM figure through Mar 2026 stood at 13.1% (up 161.0% YoY), while the FY2025 annual figure was 14.09%, up 336.0% from the prior year.
• FCF Margin slipped to 28.58% in Q1 2026, from 25.48% in the prior quarter.
• Over the last five years, FCF Margin for MD reached as high as 30.25% in Q4 2024 and fell as low as 28.58% in Q1 2026.
• The 5-year median for FCF Margin is 15.59% (2022), against an average of 6.77%.
• Annual changes were most pronounced in 2023 — FCF Margin sank 532 bps — and 2024, when it soared 1813 bps.
• A 5-year view of FCF Margin shows it stood at 17.44% in 2022, then tumbled by 30 bps to 12.13% in 2023, then surged by 149 bps to 30.25% in 2024, then declined by 16 bps to 25.48% in 2025, then sank by 212 bps to 28.58% in 2026.
• According to Business Quant data, FCF Margin over the past three periods registered 28.58%, 25.48%, and 26.77% for Q1 2026, Q4 2025, and Q3 2025 respectively.